FDA 483 - SHL Pharma LLC - July 11, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of GTT Pharma, LLC in Deerfield Beach, FL, revealed significant deficiencies in their quality system, specifically regarding the investigation of out-of-specification (OOS) results. The firm failed to adequately document conclusions and implement corrective and preventative actions for multiple OOS investigations related to drug product stability testing, leading to continued failures. This indicates a breakdown in their quality control processes for handling product deviations.
ID · a6b548f8-59f8-44de-8c9c-c5575ec5300e